Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness involves hormones and cell signals affecting hair growth.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Multiple treatments work best for hair loss.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

More plasma leptin means higher baldness risk in men.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Certain natural compounds called terpenes may help prevent prostate cancer.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.